Brochiero E, Ehrenfeld J
Department of Cellular and Molecular Biology, CEA-URA 1855 (CNRS), Laboratoire Jean-Maetz, Villefranche/Mer, France.
Kidney Blood Press Res. 1997;20(6):381-90. doi: 10.1159/000174253.
The nature of the calcium-transporting mechanisms involved in A6 cell calcium homeostasis under iso- and hypo-osmotic conditions was investigated using fura-2 (AM) as a cell calcium indicator. Under steady-state conditions, intracellular calcium (Ca2+i) was increased by Bay K8644 or by gramicidin, an ionophore which depolarises A6 cell membranes. The Ca2+i increase following calcium addition (to calcium-depleted cells) or membrane depolarisation was blocked by nifedipine but not by verapamil or omega-conotoxin, indicating that the membrane calcium permeability may be mediated by voltage-dependent and dihydropyridine-sensitive calcium channels. Ca2+i could also be increased by a hypo-osmotic shock having a linear relationship with the osmolarity change. This osmotically induced Ca2+i increase had an extracellular origin since it was absent when cells were suspended in a calcium-free medium and it was not affected by thapsigargin or TMB-8 application. In addition, it was inhibited by the calcium channel inhibitor, nifedipine. Furthermore, under hypo-osmotic conditions, an additional Ca2+i increase, sensitive to nifedipine, was measured when cells were depolarised by gramicidin or K-gluconate addition. It is proposed that the hypo-osmotically induced cell calcium increase implies the activation of voltage-dependent and nifedipine-sensitive calcium channels, presenting the same pharmacological characteristics as those involved in cell calcium homeostasis under iso-osmotic conditions. The initial Ca2+i increase was transient and stabilised to a value nevertheless higher than the iso-osmotic level; this secondary and incomplete regulatory phase did not occur in the presence of thapsigargin or TMB-8, thus providing evidence of intracellular calcium storage.
使用fura-2(AM)作为细胞钙指示剂,研究了等渗和低渗条件下A6细胞钙稳态中涉及的钙转运机制的性质。在稳态条件下,细胞内钙(Ca2+i)可通过Bay K8644或短杆菌肽增加,短杆菌肽是一种可使A6细胞膜去极化的离子载体。添加钙(到缺钙细胞)或膜去极化后Ca2+i的增加被硝苯地平阻断,但未被维拉帕米或ω-芋螺毒素阻断,这表明膜钙通透性可能由电压依赖性和二氢吡啶敏感的钙通道介导。低渗休克也可使Ca2+i增加,且与渗透压变化呈线性关系。这种渗透诱导的Ca2+i增加起源于细胞外,因为当细胞悬浮在无钙培养基中时这种增加不存在,且不受毒胡萝卜素或TMB-8应用的影响。此外,它被钙通道抑制剂硝苯地平抑制。此外,在低渗条件下,当通过添加短杆菌肽或K-葡萄糖酸盐使细胞去极化时,可检测到对硝苯地平敏感的额外Ca2+i增加。有人提出,低渗诱导的细胞钙增加意味着电压依赖性和硝苯地平敏感的钙通道被激活,其呈现出与等渗条件下细胞钙稳态中涉及的通道相同的药理学特征。最初的Ca2+i增加是短暂的,并稳定在一个仍高于等渗水平的值;在存在毒胡萝卜素或TMB-8的情况下不会出现这种继发性和不完全调节阶段,从而提供了细胞内钙储存的证据。